Apolipoprotein e and LRP1 increase early in Parkinson's disease pathogenesis

American Journal of Pathology

Volumn 179, Issue 5, 2011, Pages 2152-2156

  Wilhelmus, Micha M M ^a   Bol, John G J M ^a   Van Haastert, Elise S ^a   Rozemuller, Annemieke J M ^a   Bu, Guojun ^b   Drukarch, Benjamin ^a   Hoozemans, Jeroen J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LEWY BODY; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; APOLIPOPROTEINS E; CADAVER; FEMALE; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MALE; MELANINS; MIDDLE AGED; NERVE DEGENERATION; NEURONS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 80055001193     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.07.021     Document Type: Article

References (22)

1. E.C. Wolters, and H. Braak Parkinson's disease: premotor clinico-pathological correlations J Neural Transm Suppl 2006
2. H. Braak, K. Del Tredici, U. Rub, R.A. de Vos, E.N. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2003 197 211
3. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
4. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
5. G. Gallardo, O.M. Schluter, and T.C. Sudhof A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides Nat Neurosci 11 2008 301 308
6. K.A. Jellinger A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders Biochim Biophys Acta 1792 2009 730 740
7. D.W. Dickson, H. Fujishiro, A. DelleDonne, J. Menke, Z. Ahmed, K.J. Klos, K.A. Josephs, R. Frigerio, M. Burnett, J.E. Parisi, and J.E. Ahlskog Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease Acta Neuropathol 115 2008 437 444
8. G. Bu Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Nat Rev Neurosci 10 2009 333 344
9. M.M. Wilhelmus, R. Verhaar, G. Andringa, J.G. Bol, P. Cras, L. Shan, J.J. Hoozemans, and B. Drukarch Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson's disease brain Brain Pathol 2011 10.1111/j.1750-3639.2010.00429.x
10. T. Kanekiyo, and G. Bu Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake J Biol Chem 284 2009 33352 33359
11. Y. Namba, M. Tomonaga, H. Kawasaki, E. Otomo, and K. Ikeda Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease Brain Res 541 1991 163 166
12. M.M. Wilhelmus, I. Otte-Holler, J.J. van Triel, R. Veerhuis, M.L. Maat-Schieman, G. Bu, R.M. de Waal, and M.M. Verbeek Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells Am J Pathol 171 2007 1989 1999
13. G. Bu, H.J. Geuze, G.J. Strous, and A.L. Schwartz 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein EMBO J 14 1995 2269 2280
14. L.M. Obermoeller, I. Warshawsky, M.R. Wardell, and G. Bu Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperone J Biol Chem 272 1997 10761 10768
15. V. Ruiperez, F. Darios, and B. Davletov Alpha-synuclein, lipids and Parkinson's disease Prog Lipid Res 49 2010 420 428
16. J. Poirier, M. Hess, P.C. May, and C.E. Finch Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning Brain Res Mol Brain Res 11 1991 97 106
17. M.M. Wilhelmus, I. Otte-Holler, J. Davis, W.E. Van Nostrand, R.M. de Waal, and M.M. Verbeek Apolipoprotein E genotype regulates amyloid-beta cytotoxicity J Neurosci 25 2005 3621 3627
18. R.W. Mahley, K.H. Weisgraber, and Y. Huang Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease Proc Natl Acad Sci U S A 103 2006 5644 5651
19. S. Chang, T. ran Ma, R.D. Miranda, M.E. Balestra, R.W. Mahley, and Y. Huang Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity Proc Natl Acad Sci U S A 102 2005 18694 18699
20. C.H. Williams-Gray, A. Goris, M. Saiki, T. Foltynie, D.A. Compston, S.J. Sawcer, and R.A. Barker Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease J Neurol 256 2009 493 498
21. C.V. Zerbinatti, and G. Bu LRP and Alzheimer's disease Rev Neurosci 16 2005 123 135
22. G. Bu The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family Int Rev Cytol 209 2001 79 116